Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Clinical Evaluations & Investigations

The EU MDR and your clinical strategies: All you need to know...

2018 Highlights Include:

Your one stop shop for the latest clinical evaluations and investigations updates
  • New clinical considerations under the MDR: Competent Authority, Notified Body and industry updates
  • Best practice for applying the new MEDDEV 2.7.1 rev 4 guidance
  • Are your Post Market Clinical Follow-Up activities up to scratch?
  • Explore clinical evidence requirements for class III devices in the MDR
  • How do EUDAMED developments impact clinical evaluations and investigations?

Competent Authority and Notified Body perspectives from:
  • Health Products Regulatory Authority
  • FAMHP
  • TÜV SÜD Product Service GmbH
  • UL International (UK) Ltd.
  • TÜV Rheinland LGA Products GmbH
You’ve got questions. We’ve got the answers.

We’ll be hosting interactive panel discussions on:

  • Sharing experiences with writing a CER following MEDDEV 2.7.1 rev 4
  • Open floor Q&A session – save up your questions from the day to ask our panel
  • A chance to catch up with Competent Authority, Notified Body and industry experts

Free On-Demand Content

Webinars. Webinars. Webinars.

EU MDR Labeling Compliance: Learn the Lessons from UDI

Speakers:
Mark Cusworth, VP Research and Development, PRISYM ID
Andrew Love, VP Capability Development, Be4ward
WATCH THIS WEBINAR


Latest status and practical experience of implementing the new EU MDR

Speaker:
Bassil Akra, Vice President, Global Focus Teams (Cardiovascular, Orthopeadic and Clinical), TÜV SÜD Product Service GmbH, Germany
WATCH THIS WEBINAR